Stay updated on Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.3.3 appears in the page header. The footer now removes the HHS Vulnerability Disclosure link and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T08:28:34.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1. No changes to the study content, eligibility criteria, or listed locations are apparent.
    Difference
    0.1%
    Check dated 2025-12-01T17:43:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page shows an updated revision label from v3.2.0 to v3.3.1, which appears to be a minor update to the page's versioning information rather than content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:47:37.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The government funding status notice has been removed from the page; the rest of the study details, locations, and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:41.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the study details page remains consistent across the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:19:12.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and version upgrade to v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:10:48.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.